Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
2016 · New England Journal of Medicine · 1,010 citations
https://doi.org/10.1056/nejmoa1603800
R
Roman Chlíbek
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
130
Papers
4.6K
Citations
23
h-index
35
i10-index
Roman Chlíbek is an academic researcher. The author has contributed to research in topics: Herpesvirus Infections and Treatments & Poxvirus research and outbreaks & Hepatitis B Virus Studies. The author has an h-index of 23, co-authored 111 publications.
ORCID: 0000-0002-7387-3844Papers by this author
worksLong-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults
2015 · Vaccine · 121 citations
https://doi.org/10.1016/j.vaccine.2015.09.073
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials
2019 · Vaccine · 61 citations
https://doi.org/10.1016/j.vaccine.2019.03.043
Prevalence of Borrelia burgdorferi sensu lato infection in the Czech Republic
2025 · International Journal of Medical Microbiology · 2 citations
https://doi.org/10.1016/j.ijmm.2024.151644
Demographic characteristics of subjects.
2017 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0175525.t001
Prevalence of anti-HCV- positive and HCV RNA-positive subjects by sex/age.
2017 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0175525.t002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat